Literature DB >> 6233969

Atriopeptins: a family of potent biologically active peptides derived from mammalian atria.

D M Geller, M G Currie, K Wakitani, B R Cole, S P Adams, K F Fok, N R Siegel, S R Eubanks, G R Galluppi, P Needleman.   

Abstract

Extracts of rat atria are potent stimulators of sodium and urine excretion, and relax vascular and intestinal smooth muscle preparations. The structures of six biologically active peptides obtained from atrial extracts are reported here. Ion exchange chromatography of a low molecular weight fraction obtained by gel filtration of atrial extracts produced two natriuretic fractions: the first induced relaxation of intestinal smooth muscle strips only, whereas the second also relaxed vascular strips as well. From the first fraction four pure biologically active peptides obtained by reverse phase HPLC have been sequenced: the 21 amino acid peptide, designated atriopeptin I, and three homologs (des- ser1 -, des- ser1 -ser2-, and des- ser21 - atriopeptin I). From the second fraction two pure biologically active peptides were obtained, which had C-terminal extensions of atriopeptin I: atriopeptins II (23 amino acid residues) and III (24 residues), having respectively phe-arg and phe-arg-tyr C-termini. These results suggest that this family of six peptides, sharing the same 17 membered ring formed by an internal cystine disulfide, is derived from a common high molecular weight precursor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6233969     DOI: 10.1016/0006-291x(84)91258-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Effect of atrial peptides on aldosterone production.

Authors:  K Atarashi; P J Mulrow; R Franco-Saenz
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

Review 2.  Biologically active atrial peptides.

Authors:  B J Ballerman; B M Brenner
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

3.  Electronmicroscopical, immunohistochemical, immunocytochemical and biological evidence for the occurrence of cardiac hormones (ANP/CDD) in chondrichthyes.

Authors:  M Reinecke; D Betzler; W G Forssmann; M Thorndyke; U Askensten; S Falkmer
Journal:  Histochemistry       Date:  1987

Review 4.  The biochemistry and molecular biology of atrial natriuretic factor.

Authors:  T G Flynn; P L Davies
Journal:  Biochem J       Date:  1985-12-01       Impact factor: 3.857

5.  Infrared spectroscopic evidence of conformational transitions of an atrial natriuretic peptide.

Authors:  W K Surewicz; H H Mantsch; G L Stahl; R M Epand
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 6.  The atrial natriuretic factor.

Authors:  J Genest
Journal:  Br Heart J       Date:  1986-10

7.  Cardiodilatin-immunoreactive neurons in the hypothalamus of Tupaia.

Authors:  W G Forssmann; V Mutt
Journal:  Anat Embryol (Berl)       Date:  1985

Review 8.  The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Biomed Pharmacother       Date:  2017-06-07       Impact factor: 6.529

9.  Plasma atrial natriuretic peptide levels in essential hypertension after treatment with verapamil.

Authors:  B Kokkas; P Kotridis; M Karamouzis; I Kanonidis; G Sakadamis; G Dadous; S Haritos; P Kyriakoui; P C Papadopoulos; V Mirtsou-Fidani; C L Papadopoulos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jan-Mar       Impact factor: 2.441

10.  Plasma atrial natriuretic peptide in essential hypertension after treatment with terazocin.

Authors:  P Kotridis; B Kokkas; P Kyriakou; M Karamouzis; G Salpigidis; C Karantona; J Karadoumanis; T Ginis; O Goulis; P C Papadopoulos; C Vakalopoulos; G Sakantamis; A Dimitriadou; V Mirtsou-Fidani; C L Papadopoulos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Apr-Jun       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.